Denali Therapeutics Inc.

15.51
0.64 (4.30%)
At close: Apr 24, 2025, 3:59 PM
15.03
-3.10%
Pre-market: Apr 25, 2025, 04:39 AM EDT

Denali Therapeutics Revenue

Denali Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Denali Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
422
Market Cap
2.25B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 -100.00%
Dec 31, 2023 330.53M +204.74%
Dec 31, 2022 108.46M +122.90%
Dec 31, 2021 48.66M -85.50%
Dec 31, 2020 335.66M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.